PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
ASPN vs. PLTR
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between ASPN and PLTR is 0.37, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.4

Performance

ASPN vs. PLTR - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Aspen Aerogels, Inc. (ASPN) and Palantir Technologies Inc. (PLTR). The values are adjusted to include any dividend payments, if applicable.

-50.00%0.00%50.00%100.00%150.00%200.00%AugustSeptemberOctoberNovemberDecember2025
-45.90%
152.18%
ASPN
PLTR

Key characteristics

Sharpe Ratio

ASPN:

0.04

PLTR:

5.19

Sortino Ratio

ASPN:

0.87

PLTR:

5.30

Omega Ratio

ASPN:

1.10

PLTR:

1.68

Calmar Ratio

ASPN:

0.04

PLTR:

5.75

Martin Ratio

ASPN:

0.12

PLTR:

36.14

Ulcer Index

ASPN:

30.19%

PLTR:

9.35%

Daily Std Dev

ASPN:

92.69%

PLTR:

65.17%

Max Drawdown

ASPN:

-91.34%

PLTR:

-84.62%

Current Drawdown

ASPN:

-80.02%

PLTR:

-12.88%

Fundamentals

Market Cap

ASPN:

$1.04B

PLTR:

$157.73B

EPS

ASPN:

$0.02

PLTR:

$0.21

PE Ratio

ASPN:

636.00

PLTR:

341.76

PEG Ratio

ASPN:

0.00

PLTR:

2.97

Total Revenue (TTM)

ASPN:

$329.61M

PLTR:

$2.04B

Gross Profit (TTM)

ASPN:

$135.76M

PLTR:

$1.65B

EBITDA (TTM)

ASPN:

$128.12M

PLTR:

$323.94M

Returns By Period

In the year-to-date period, ASPN achieves a 7.07% return, which is significantly higher than PLTR's -5.10% return.


ASPN

YTD

7.07%

1M

5.56%

6M

-45.90%

1Y

6.27%

5Y*

4.27%

10Y*

5.18%

PLTR

YTD

-5.10%

1M

0.36%

6M

151.12%

1Y

337.62%

5Y*

N/A

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

ASPN vs. PLTR — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ASPN
The Risk-Adjusted Performance Rank of ASPN is 5050
Overall Rank
The Sharpe Ratio Rank of ASPN is 4646
Sharpe Ratio Rank
The Sortino Ratio Rank of ASPN is 5656
Sortino Ratio Rank
The Omega Ratio Rank of ASPN is 5353
Omega Ratio Rank
The Calmar Ratio Rank of ASPN is 4747
Calmar Ratio Rank
The Martin Ratio Rank of ASPN is 4747
Martin Ratio Rank

PLTR
The Risk-Adjusted Performance Rank of PLTR is 9999
Overall Rank
The Sharpe Ratio Rank of PLTR is 100100
Sharpe Ratio Rank
The Sortino Ratio Rank of PLTR is 9999
Sortino Ratio Rank
The Omega Ratio Rank of PLTR is 9898
Omega Ratio Rank
The Calmar Ratio Rank of PLTR is 9999
Calmar Ratio Rank
The Martin Ratio Rank of PLTR is 9999
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

ASPN vs. PLTR - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Aspen Aerogels, Inc. (ASPN) and Palantir Technologies Inc. (PLTR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for ASPN, currently valued at 0.04, compared to the broader market-2.000.002.004.000.045.19
The chart of Sortino ratio for ASPN, currently valued at 0.87, compared to the broader market-4.00-2.000.002.004.006.000.875.30
The chart of Omega ratio for ASPN, currently valued at 1.10, compared to the broader market0.501.001.502.001.101.68
The chart of Calmar ratio for ASPN, currently valued at 0.04, compared to the broader market0.002.004.006.000.045.75
The chart of Martin ratio for ASPN, currently valued at 0.12, compared to the broader market-10.000.0010.0020.0030.000.1236.14
ASPN
PLTR

The current ASPN Sharpe Ratio is 0.04, which is lower than the PLTR Sharpe Ratio of 5.19. The chart below compares the historical Sharpe Ratios of ASPN and PLTR, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.001.002.003.004.005.006.00AugustSeptemberOctoberNovemberDecember2025
0.04
5.19
ASPN
PLTR

Dividends

ASPN vs. PLTR - Dividend Comparison

Neither ASPN nor PLTR has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

ASPN vs. PLTR - Drawdown Comparison

The maximum ASPN drawdown since its inception was -91.34%, which is greater than PLTR's maximum drawdown of -84.62%. Use the drawdown chart below to compare losses from any high point for ASPN and PLTR. For additional features, visit the drawdowns tool.


-80.00%-60.00%-40.00%-20.00%0.00%AugustSeptemberOctoberNovemberDecember2025
-80.02%
-12.88%
ASPN
PLTR

Volatility

ASPN vs. PLTR - Volatility Comparison

The current volatility for Aspen Aerogels, Inc. (ASPN) is 15.06%, while Palantir Technologies Inc. (PLTR) has a volatility of 17.91%. This indicates that ASPN experiences smaller price fluctuations and is considered to be less risky than PLTR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


10.00%15.00%20.00%25.00%30.00%AugustSeptemberOctoberNovemberDecember2025
15.06%
17.91%
ASPN
PLTR

Financials

ASPN vs. PLTR - Financials Comparison

This section allows you to compare key financial metrics between Aspen Aerogels, Inc. and Palantir Technologies Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab